| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |